510(k) · Cleared
ClearedVitalFlow Set with Balance Biosurface
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Medtronic, Inc. · QJZ Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure
Cleared on Sep 12, 2024 as substantially equivalent to K191407 (Fresenius Medical Care Renal Therapies Group, LLC, 2020) after a 164-day review. Its family tree reaches back 6 generations to 1993. 1 later device descends from it.
- Decided
- Sep 12, 2024
- Review
- 164 days
- Class
- Class II
- Product code
- QJZ
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 6 generations to K932252 (1993). 16 ancestors in all, the oldest K852698 (1985). 1 later device descends from it, 1 citing it directly.
- Root · 6 generations backK932252 Affinity Hollow Fiber OxygenatorAvecor Cardiovascular, Inc. · 1993
- 5 generations backK992559 Hollow Fiber Membrane Oygenator Quadrox Hmo 1010Jostra Bentley · 1999
- 4 generations backK030264 Quandrox Safeline Hollow Fiber Membrane Oxygenator, Model Hmo 2030Jostra AG · 2003
- 3 generations backK061628 Jostra Quadrox D Safeline Diffusion Membrane Oxygenator, Model Hmod…Maquet Cardiopulmonary, AG · 2006
- 2 generations backK072362 Novalung Surgical Lung Assist (Sla) Membrane LungNovalung GmbH · 2007
- 1 generation backK191407 Novalung SystemFresenius Medical Care Renal Therapies Group, LLC · 2020 · Recalled
- This deviceK240880 VitalFlow Set with Balance BiosurfaceMedtronic, Inc. · 2024
- Descendant · cites it directly · 0 of its ownK261335 VitalFlow Set with Balance™ BiosurfaceMedtronic, Inc. · 2026
Most influential descendants
Showing 1 of 1 · See all- K261335VitalFlow Set with Balance™ BiosurfaceMedtronic, Inc. · 2026 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −6 | K932252 | Affinity Hollow Fiber Oxygenator | Avecor Cardiovascular, Inc. | 1993 | — |
| −5 | K992559 | Hollow Fiber Membrane Oygenator Quadrox Hmo 1010 | Jostra Bentley | 1999 | — |
| −4 | K030264 | Quandrox Safeline Hollow Fiber Membrane Oxygenator, Model Hmo 2030 | Jostra AG | 2003 | — |
| −3 | K061628 | Jostra Quadrox D Safeline Diffusion Membrane Oxygenator, Model Hmod 2030 | Maquet Cardiopulmonary, AG | 2006 | — |
| −2 | K072362 | Novalung Surgical Lung Assist (Sla) Membrane Lung | Novalung GmbH | 2007 | — |
| −1 | K191407 | Novalung System | Fresenius Medical Care Renal Therapies Group, LLC | 2020 | 2 |
| 0 (this device) | K240880 | VitalFlow Set with Balance Biosurface | Medtronic, Inc. | 2024 | — |
| +1 | K261335 | VitalFlow Set with Balance™ Biosurface | Medtronic, Inc. | 2026 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1985 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1996 | 1 | 0 |
| 1998 | 1 | 0 |
| 2000 | 1 | 0 |
| 2009 | 1 | 0 |
| 2014 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in QJZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new QJZ device
- #1 K261335 VitalFlow Set with Balance™ Biosurfacescore 13.6 · 7 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K191407 | Novalung SystemSummary page 5…Class II (with special controls) Regulation Number: 21 CFR 870.4100 Product Codes: QJZ, QNR, BYS, QWF Name of Predicate Device: Novalung System (K191407) Name of Reference Devices: Tubing and Accessories Sets for Extracorporeal Membrane Oxygenation (ECMO… | 2020 |
| † | K223168 | Tubing and Accessories Sets for Extracorporeal Membrane Oxygenation (ECMO) with Balance™… | 2023 |
| † | K232767 | Nautilus VF ECMO Oxygenator | 2023 |
| † | K223898 | VitalFlowTM Centrifugal Pump | 2023 |
| † | K171979 | Tubing Pack | 2017 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K261335 | VitalFlow Set with Balance™ Biosurface | 2026 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 31 years and passes through 7 companies; a new generation was cleared every 4.6 years on median.
- 5 of the 16 ancestors have a recall of any class.
- Of its descendants, K261335 (Medtronic, Inc., 2026) has gone furthest, with 0 descendants of its own.
- 1 other device also cites its predicate K191407.
How does its category compare?
All QJZ devicesQJZ Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.
FDA decisions per year · QJZ
2in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · QJZ
Too few QJZ 510(k)s in any year since 2007 to give a median.
Recalls per year · QJZ
1in 2021
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · QJZ
128in 2025
MAUDE reports naming product code QJZ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 1 | — | 0 | 17 |
| 2021 | 0 | — | 1 | 52 |
| 2022 | 0 | — | 0 | 53 |
| 2023 | 0 | — | 0 | 104 |
| 2024 | 2 | — | 0 | 75 |
| 2025 | 0 | — | 0 | 128 |
| 2026 | 1 | — | 0 | — |
What is it indicated for?
The VitalFlow Set with Balance Biosurface is indicated for respiratory/cardiopulmonary support up to 48 hours that
provides assisted extracorporeal circulation and physiologic gas exchange (oxygenation) of the patient's blood in adults
with acute respiratory failure or acute cardiopulmonary failure, where other available treatment options have failed, and
continued clinical deterioration is expected or the risk of death is imminent.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K240880 · printed Nov 4, 2026
Cite this page
510(k) Report. “K240880: VitalFlow Set with Balance Biosurface.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K240880
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026